Filed before 2025Filed 30 December 2022
Cardurion Pharmaceuticals, Inc. raised $17.5M
Cardurion Pharmaceuticals, Inc., a biotech company based in Burlington, MA, raised $17.5M in a new debt round, according to a filing dated 30 December 2022.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 30 December 2022
- Round
- Debt round
- Amount sold
- $17.5M
- Offering size
- $17.5M
- Investors so far
- 2
- Based in
- Burlington, MA
Investors on the board
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
1 director of this company is named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 67% of the 1,764 tracked raises with an amount filed in 2022, and than 64% of the 142 in biotech.
Cardurion Pharmaceuticals, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 24 Jul 2024 | New filing | $260M | Another raise |
| 30 Dec 2022 | New filing | $17.5M | This raise |
| 3 Nov 2021 | New filing | $46.1M | Not tracked |
| 20 Nov 2019 | New filing | $10M | Another raise |
More with Polaris on the board
- Auron Therapeutics, Inc.$7.12M
- MeridianMade, Inc.$20.3M
- ByHeart, Inc.$95.5M
- Icelandic Provisions, Inc.$7.08M
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.